4.97
-0.13 (-2.55%)
| Penutupan Terdahulu | 5.10 |
| Buka | 5.01 |
| Jumlah Dagangan | 20,931 |
| Purata Dagangan (3B) | 144,173 |
| Modal Pasaran | 260,265,776 |
| Harga / Jualan (P/S) | 5.46 |
| Harga / Buku (P/B) | 6.62 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | -63.24% |
| Margin Operasi (TTM) | -79.16% |
| EPS Cair (TTM) | -0.980 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -9.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 52.12% |
| Nisbah Semasa (MRQ) | 10.47 |
| Aliran Tunai Operasi (OCF TTM) | -24.17 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -8.84 M |
| Pulangan Atas Aset (ROA TTM) | -21.77% |
| Pulangan Atas Ekuiti (ROE TTM) | -52.88% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Sight Sciences, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | -2.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.20 |
|
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 20.87% |
| % Dimiliki oleh Institusi | 50.88% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Kck Ltd. | 30 Sep 2025 | 4,374,975 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 8.00 (Morgan Stanley, 60.97%) | Pegang |
| Median | 6.00 (20.72%) | |
| Rendah | 4.00 (Citigroup, -19.52%) | Pegang |
| Purata | 6.00 (20.72%) | |
| Jumlah | 1 Beli, 3 Pegang | |
| Harga Purata @ Panggilan | 5.69 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Morgan Stanley | 02 Dec 2025 | 8.00 (60.97%) | Pegang | 8.30 |
| 10 Nov 2025 | 6.00 (20.72%) | Pegang | 6.52 | |
| Piper Sandler | 07 Nov 2025 | 5.00 (0.60%) | Pegang | 5.82 |
| Lake Street | 21 Oct 2025 | 7.00 (40.85%) | Beli | 5.16 |
| Citigroup | 07 Oct 2025 | 4.00 (-19.52%) | Pegang | 3.47 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| HAYDEN JEREMY B. | - | 8.10 | -44,850 | -363,285 |
| RODBERG JAMES | - | 8.30 | -2,518 | -20,899 |
| Jumlah Keseluruhan Kuantiti Bersih | -47,368 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -384,184 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 8.20 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| RODBERG JAMES | Pegawai | 02 Dec 2025 | Jual (-) | 2,518 | 8.30 | 20,899 |
| HAYDEN JEREMY B. | Pegawai | 25 Nov 2025 | Jual automatik (-) | 44,850 | 8.10 | 363,285 |
| HAYDEN JEREMY B. | Pegawai | 25 Nov 2025 | Pelaksanaan pilihan | 44,850 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |